1% preservative-free lidocaine + Phenylephrine 1.0%/ Ketorolac 0.3%
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
80
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pain Reduction
Conditions
Pain Reduction
Trial Timeline
Feb 1, 2022 → Aug 1, 2023
NCT ID
NCT04829799About 1% preservative-free lidocaine + Phenylephrine 1.0%/ Ketorolac 0.3%
1% preservative-free lidocaine + Phenylephrine 1.0%/ Ketorolac 0.3% is a approved stage product being developed by Omeros Corporation for Pain Reduction. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT04829799. Target conditions include Pain Reduction.
Hype Score Breakdown
Clinical
30
Activity
20
Company
5
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04829799 | Approved | Withdrawn |
Competing Products
20 competing products in Pain Reduction